IS7978A - Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum - Google Patents

Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum

Info

Publication number
IS7978A
IS7978A IS7978A IS7978A IS7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A
Authority
IS
Iceland
Prior art keywords
preparation
basic compound
alkaline compounds
additional salts
polyacidic
Prior art date
Application number
IS7978A
Other languages
English (en)
Inventor
Shibuya Kimiyuki
Ohgiya Tadaaki
Matsuda Takayuki
Original Assignee
Kowa Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co., Ltd. filed Critical Kowa Co., Ltd.
Publication of IS7978A publication Critical patent/IS7978A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
IS7978A 2003-02-28 2005-08-12 Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum IS7978A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (1)

Publication Number Publication Date
IS7978A true IS7978A (is) 2005-08-12

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7978A IS7978A (is) 2003-02-28 2005-08-12 Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum

Country Status (21)

Country Link
US (2) US7750150B2 (is)
EP (1) EP1598346B1 (is)
JP (2) JP4594863B2 (is)
KR (1) KR101106127B1 (is)
CN (2) CN1753886B (is)
AT (1) ATE554083T1 (is)
AU (1) AU2004215523B2 (is)
BR (1) BRPI0407908A (is)
CA (1) CA2516822C (is)
DK (1) DK1598346T3 (is)
EA (1) EA009045B1 (is)
ES (1) ES2384517T3 (is)
IL (1) IL170093A (is)
IS (1) IS7978A (is)
MX (1) MXPA05009129A (is)
MY (1) MY140618A (is)
NO (1) NO331272B1 (is)
NZ (1) NZ541716A (is)
PL (1) PL378292A1 (is)
TW (2) TWI374136B (is)
WO (1) WO2004076441A1 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
NZ544803A (en) 2003-08-29 2009-11-27 Kowa Co Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
EP1932841B1 (en) 2005-08-30 2014-01-01 Asahi Kasei Pharma Corporation Sulfonamide compound
WO2008105058A1 (ja) * 2007-02-27 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド化合物
AU2008220104B2 (en) 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative
US8232292B2 (en) 2007-07-02 2012-07-31 Asahi Kasei Pharma Corporation Sulfonamide compound and crystal thereof
JP5631738B2 (ja) * 2007-11-30 2014-11-26 オプティチューン オサケ ユキチュア 新規シロキサンポリマー組成物
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
WO2011145340A1 (ja) 2010-05-19 2011-11-24 興和株式会社 非アルコール性脂肪性肝炎の予防及び/又は治療剤
AU2016277859B2 (en) * 2015-06-17 2019-08-01 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
WO2018092765A1 (ja) * 2016-11-15 2018-05-24 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
WO1998054153A1 (en) * 1997-05-26 1998-12-03 Kowa Company, Ltd. Novel cyclic diamine compounds and medicine containing the same
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
EP1571144A4 (en) * 2002-12-12 2007-08-01 Kowa Co HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
CA2516822C (en) 2012-09-25
EA200501379A1 (ru) 2006-02-24
NO331272B1 (no) 2011-11-14
AU2004215523A1 (en) 2004-09-10
US7750150B2 (en) 2010-07-06
ES2384517T3 (es) 2012-07-06
EA009045B1 (ru) 2007-10-26
US8518936B2 (en) 2013-08-27
MY140618A (en) 2009-12-31
CN102702171A (zh) 2012-10-03
CN1753886A (zh) 2006-03-29
AU2004215523B2 (en) 2009-07-16
IL170093A (en) 2012-02-29
EP1598346B1 (en) 2012-04-18
KR20050105218A (ko) 2005-11-03
BRPI0407908A (pt) 2006-02-14
TW200504052A (en) 2005-02-01
CN1753886B (zh) 2012-07-18
KR101106127B1 (ko) 2012-01-20
PL378292A1 (pl) 2006-03-20
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
DK1598346T3 (da) 2012-05-29
CN102702171B (zh) 2014-09-10
JP4594863B2 (ja) 2010-12-08
US20060079688A1 (en) 2006-04-13
NZ541716A (en) 2007-11-30
CA2516822A1 (en) 2004-09-10
TW201202218A (en) 2012-01-16
EP1598346A1 (en) 2005-11-23
JPWO2004076441A1 (ja) 2006-06-01
US20100234599A1 (en) 2010-09-16
NO20054100D0 (no) 2005-09-02
ATE554083T1 (de) 2012-05-15
EP1598346A4 (en) 2007-08-15
TWI374136B (en) 2012-10-11
JP5180998B2 (ja) 2013-04-10
WO2004076441A1 (ja) 2004-09-10
JP2010235635A (ja) 2010-10-21
TWI355384B (en) 2012-01-01

Similar Documents

Publication Publication Date Title
DK1656386T3 (da) Fremgangsmåde til fremstilling af bisphosphonsyreforbindelser
DK1781683T3 (da) Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
CR9369A (es) Compuestos de peridil acido acetico
BRPI0514543A (pt) sais de metanossulfonato de abiraterona-3-ésteres e recuperação de sais de abiraterona-3-ésteres de solução em éter de terc-butila de metila
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
DK1881957T3 (da) Fremgangsmåde til fremstilling af biproduktfattige methylglycin-N,N-diedikkesyre-trialkalimetalsalte
IL178771A0 (en) 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
ATE420875T1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3- indolyl)-butylü-1-piperazinyl)-benzofuran-2- carboxamid
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
NO20053208L (no) Metode for reduktiv dehalogenering.
WO2007144363A3 (en) Process for the preparation of 6-alpha, 9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-s-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl
DE602006005488D1 (de) Verfahren zur herstellung von losartanderivaten durch chlorierung und reduktion der entsprechenden 1h-imidazol-5-carbaldehyde
DE602004022874D1 (de) Biotransformation von colchicinoidverbindungen
RU2005105549A (ru) Способ получения коньюгатов гепарина
TW200700370A (en) Producing method of haloalkylether compounds
RU2018123595A (ru) Способ получения хелатообразующего агента
PL407772A1 (pl) Krystaliczna forma kompleksu trihydrat chlorku [di(2-amino-5-guanidynopentano)(4,4'-dipirydylo) miedzi (II)] i sposób jej wytwarzania
TH84983B (th) พหุสัณฐานไดแบนโดรเนท b
UY27120A1 (es) Procedimiento para la preparación de la sal del ácido (d)-tartárico
NO20002497L (no) Fremgangsmåte for fremstilling av hydroksyforbindelser